— Know what they know.
Not Investment Advice

LFSC

F/M Emerald Life Sciences Innovation ETF
1W: -2.4% 1M: -5.6% 3M: -6.4% YTD: +19.8% 1Y: +47.1%
$43.40
-0.05 (-0.13%)
 
Weekly Expected Move ±2.7%
$41 $42 $43 $45 $46
ETF NASDAQ · AUM $115.9M

Portfolio Health Summary

IS Overall Score
46.2
★★★★★
Altman Z-Score
19.96
Safe
Weight Coverage
96%
of portfolio analyzed
Holdings Matched
35
with fundamental data

InsiderStreet Scorecard

★★★★★ 46.2
Profitability
36.8
Balance Sheet
51.3
Earnings Quality
53.3
Growth
57.6
Value
34.3
Momentum
66.6
Safety
71.8

Top Holdings: Score Breakdown

Risk & Quality Signals

Altman Z-Score
19.96
Safe Zone (>2.99)
Piotroski F-Score
4.4 / 9
Moderate
Beneish M-Score
-1.84
Unlikely Manipulator
Credit Score
—
Earnings Quality
53.3 / 100

Portfolio Valuation

P/E
95.73x
P/B
8.61x
P/S
10.41x
EV/EBITDA
71.80x
EV/Revenue
10.53x
P/FCF
88.63x
P/OCF
59.43x
PEG
-15.82x
Earnings Yield
1.04%
FCF Yield
1.13%
OCF Yield
1.68%
Median P/E
-8.28x

Growth & Shareholder Returns

Year-over-Year Growth

Revenue +31.4%
Net Income +17.0%
EPS +28.6%
FCF +5.8%
EBITDA +8.9%
Op. Income —

Compound Growth Rates

Rev CAGR 3Y +62.6%
Rev CAGR 5Y +31.7%
EPS CAGR 3Y -6.0%
EPS CAGR 5Y -2.5%
FCF CAGR 3Y +33.7%
FCF CAGR 5Y +8.5%
EBITDA CAGR 3Y +20.1%
EBITDA CAGR 5Y -1.9%
Payout Ratio
0.00%
Buyback Yield
0.51%
Dividend Yield
0.00%
Total Shareholder Return
-5.20%

Earnings Stability

Monte Carlo Price Simulation

Geometric Brownian Motion with 1,000 antithetic paths over 1 year, seeded from 483 days of historical volatility. Percentile bands show the range of statistically plausible outcomes — this is a statistical model, not a forecast.

Current Price
$43.40
Median 1Y
$55.67
5th Pctile
$34.72
95th Pctile
$89.24
Ann. Volatility
28.2%
25th–75th percentile 5th–95th percentile Median path Historical
All Ratios & Metrics
Valuation (12)
MetricValue
Portfolio P/E 95.73
Portfolio P/B 8.61
Portfolio P/S 10.41
EV/EBITDA 71.80
EV/Revenue 10.53
P/FCF 88.63
P/OCF 59.43
PEG -15.82
Earnings Yield 1.04%
FCF Yield 1.13%
OCF Yield 1.68%
Median P/E -8.28
Profitability & Returns (9)
MetricValue
Gross Margin 72.27%
Operating Margin -12.57%
Net Margin -17.29%
FCF Margin -8.76%
ROE -15.59%
ROA -8.56%
ROIC -7.39%
ROCE —
Asset Turnover —
Leverage & Solvency (6)
MetricValue
Debt/Equity 0.52
Debt/Assets 0.28
Net Debt/EBITDA -2.03
Interest Coverage -5.51
Current Ratio 3.87
Quick Ratio 3.58
Efficiency (4)
MetricValue
Asset Turnover —
Inventory Turnover —
Receivables Turnover —
Payables Turnover —
Growth — YoY (6)
MetricValue
Revenue Growth 31.43%
Net Income Growth 16.95%
EPS Growth 28.63%
FCF Growth 5.77%
EBITDA Growth 8.87%
Op. Income Growth —
Growth — CAGR (16)
MetricValue
Revenue CAGR 3Y 62.63%
Revenue CAGR 5Y 31.74%
Revenue CAGR 10Y —
EPS CAGR 3Y -6.05%
EPS CAGR 5Y -2.51%
EPS CAGR 10Y —
FCF CAGR 3Y 33.68%
FCF CAGR 5Y 8.51%
FCF CAGR 10Y —
EBITDA CAGR 3Y 20.14%
EBITDA CAGR 5Y -1.91%
EBITDA CAGR 10Y —
Net Income CAGR 3Y -4.05%
Net Income CAGR 5Y -2.17%
Op. Income CAGR 3Y —
Op. Income CAGR 5Y —
Quality Scores (13)
MetricValue
IS Overall 46.2
IS Profitability 36.8
IS Balance Sheet 51.3
IS Earnings Quality 53.3
IS Growth 57.6
IS Value 34.3
IS Momentum 66.6
IS Safety 71.8
IS Quality 54.2
Altman Z-Score 19.96
Piotroski F-Score 4.37
Beneish M-Score -1.84
Credit Score —
Dividends & Payout (4)
MetricValue
Dividend Yield 0.00%
Payout Ratio 0.00%
Buyback Yield 0.51%
Total Shareholder Return -5.20%
Growth Stability (4)
MetricValue
Revenue Stability 0.751
Earnings Stability 0.518
Earnings Persistence 0.679
Margin Stability 0.772
Medians (3)
MetricValue
Median P/E -8.28
Median P/B 5.29
Median Dividend Yield —
Coverage Meta (3)
MetricValue
Weight Coverage % 95.57%
Holdings Matched 35
Total Holdings 39

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms